May - 2021
| Previous Next | Showing Journal 7 of 10 |
Tocilizumab in Hospitalized Patients with Severe Covid-19 PneumoniaI Rosas, N Brau, M Waters et al New Eng J Med, 2021, 384:1503-1516 This page is only available to Crit-IQ subscribers. To view the rest of this review and gain access to our vast array of critical care teaching tools including podcasts, vodcasts, modules, exam preparation tools, teaching aids and much more, login here, or Become a Member to register |
May |
Previous Comments
No Comments yet.
Comment
Interleukin-6 is released in response to infection and stimulates inflammatory pathways as part of the acute-phase response. Tocilizumab is a monoclonal antibody that inhibits both membrane-bound and soluble interleukin-6 receptors and are used to...